Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025)

Palomino Laboratories (PALX) has 4 years of Other Accumulated Expenses data on file, last reported at $2740.0 in Q3 2025.

• For the quarter ending Q3 2025, Other Accumulated Expenses fell 93.88% year-over-year to $2740.0; the trailing twelve-month figure through Sep 2025 stood at $2740.0 (down 93.88% YoY), and the FY2024 full-year result was $3140.0, down 90.19% from the prior year.
• Other Accumulated Expenses retreated to $2740.0 in Q3 2025, from $6500.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $44750.0 in Q3 2024 to a low of $2250.0 in Q1 2025.
• A 4-year average of $20347.8 and a median of $15000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses jumped 113.33% in 2023 and slumped 93.88% in 2025, its largest moves.
• Tracing PALX's Other Accumulated Expenses over 4 years: stood at $15000.0 in 2022, then jumped by 113.33% to $32000.0 in 2023, then sank by 90.19% to $3140.0 in 2024, then decreased by 12.74% to $2740.0 in 2025.
• Business Quant data shows PALX's Other Accumulated Expenses at $2740.0 in Q3 2025, $6500.0 in Q2 2025, and $2250.0 in Q1 2025.